Bristol-Myers Squibb
BMY
#173
Rank
A$174.32 B
Marketcap
A$85.60
Share price
0.60%
Change (1 day)
0.04%
Change (1 year)

Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: A$174.32 Billion

As of February 2026 Bristol-Myers Squibb has a market cap of A$174.32 Billion. This makes Bristol-Myers Squibb the world's 173th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bristol-Myers Squibb from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$174.32 B4.97%
2025A$166.06 B-11.7%
2024A$188.07 B22.73%
2023A$153.24 B-31.83%
2022A$224.80 B17.76%
2021A$190.89 B4.72%
2020A$182.29 B-10.76%
2019A$204.26 B70.47%
2018A$119.82 B-6.73%
2017A$128.47 B-5.18%
2016A$135.49 B-13.61%
2015A$156.84 B31.55%
2014A$119.22 B21.93%
2013A$97.78 B91.29%
2012A$51.11 B-12.23%
2011A$58.23 B31.49%
2010A$44.29 B-7.8%
2009A$48.03 B-26.37%
2008A$65.23 B8.95%
2007A$59.87 B-8.59%
2006A$65.50 B6.58%
2005A$61.46 B-4.65%
2004A$64.45 B-13.64%
2003A$74.64 B-7.01%
2002A$80.27 B-59.06%
2001A$196.08 B-24.1%
2000A$258.33 B33.52%
1999A$193.48 B-10.96%
1998A$217.31 B50.65%
1997A$144.25 B110.12%
1996A$68.65 B

End of Day market cap according to different sources

On Feb 21st, 2026 the market cap of Bristol-Myers Squibb was reported to be:

A$174.32 Billion
by Nasdaq info icon info icon
A$174.32 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$824.67 B 373.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$443.75 B 154.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$213.83 B 22.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$560.70 B 221.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.343 T 670.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$285.08 B 63.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$160.27 B-8.06%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$39.77 B-77.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$430.95 B 147.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$446.74 B 156.26%๐Ÿ‡ฌ๐Ÿ‡ง UK